ResearcherArmy Medical UniversityNo recent work listed

Peng Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8366-0308; OpenAlex author ID A5103136900. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

GATA2-Mediated Transcriptional Activation of Notch3 Promotes Pancreatic Cancer Liver Metastasis. First author DOI 10.14348/molcells.2022.2176 ↗
siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo. Co-author DOI 10.1042/bsr20140124 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

LeiDa Zhang · 1 shared paper, 2022 · strength 0.19
- Paper GATA2-Mediated Transcriptional Activation of Notch3 Promotes Pancreatic Cancer Liver Metastasis. DOI 10.14348/molcells.2022.2176 ↗
Heng Lin · 1 shared paper, 2022 · strength 0.19
- Paper GATA2-Mediated Transcriptional Activation of Notch3 Promotes Pancreatic Cancer Liver Metastasis. DOI 10.14348/molcells.2022.2176 ↗
Lei-Da Zhang · 1 shared paper, 2015 · strength 0.06
- Paper siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo. DOI 10.1042/bsr20140124 ↗
Ping Bie · 1 shared paper, 2015 · strength 0.06
- Paper siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo. DOI 10.1042/bsr20140124 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.